Name

sibrotuzumab

Alternate Names

BIBH1

Abbreviations

BIBH-1

Category

Chemotherapy

Subcategory

Cytostatic agent--monoclonal antibody

NSC Number

None

Primary Site

Breast
colorectal
lung
other cancer
pancreatic

Histology

None

Remarks

Phase I Monoclonal antibody with cytostatic properties. (human FAP (fibro-blast activation protein) Boehringer-Ingelheim Pharmaceuticals.

Coding

This drug should be coded
Glossary